Multidisciplinaire Richtlijn ME

Bijlage 9: Literatuur

De literatuurlijst uit het preconcept is aangevuld en voorzien van links voor publicaties die gratis online te vinden zijn.

Van de meeste publicaties die niet vrij verkrijgbaar zijn beschikken wij eveneens over de volledige tekst.

Volledige tekst gevraagd
In enkele gevallen hebben wij de volledige tekst van een publicatie nog niet. Dit staat in de lijst vermeld. Kunt u ons aan een ontbrekende tekst helpen, dan vernemen wij dat graag.

Richtlijnen voor ME

Multidisciplinaire Richtlijn ME

Literatuur

Voorlopige groslijst

  1. Acheson ED (1956), “A New Clinical Entity?”, Leading Article, Lancet, 26 mei, pp. 789-90
  2. Acheson ED (1959), “The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease, and epidemic neuromyasthenia”, Am J Med Apr;26(4):569-95, PMID: 13637100
  3. Agliari E, Barra A, Vidal KG, Guerra F (2012), “Can persistent Epstein-Barr virus infection induce chronic fatigue syndrome as a Pavlov reflex of the immune response?”, J Biol Dyn 6(2):740-62, PMID: 22873615
  4. Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo S-C, Klimas N, Komaroff AL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, Genfi A, Bhat M, Zheng HQ, Wang R, Bingjie Li B, Hung G-C, Lee LL, Sameroff S, Heneine W, Coffin J, Hornig M, Lipkin WI (2012), “A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus”, mBio 3 (5), 18 september, doi:10.1128/mBio.00266-12
  5. Aspler AL, Bolshin C, Vernon SD, Broderick G (2008), “Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood”, Behav Brain Funct, Sep 26;4:44, PMID: 18822143
  6. Badham SP, Hutchinson CV (2013), “Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome”, Graefes Arch Clin Exp Ophthalmol, Aug 6 [Epub ahead of print], PMID: 23918092 – full text wanted
  7. Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess S (2005), “A Chronic Fatigue Syndrome – related proteome in human cerebrospinal fluid”, BMC Neurol, Dec 1;5:22, doi:10.1186/1471-2377-5-22, PMID: 16321154
  8. Bateman L (2007), “Chronic Fatigue Syndrome and the Exercise Conundrum”, ProHealth.com, augustus
  9. Bateman L (2015), “Pearls of Wisdom from a CFS Physician“, Solve ME/CFS Initiative, februari (update van: The CFIDS Chronicle, voorjaar 2008)
  10. Behan PO (1978), “Post-infectuous encephalomyelitis: some aetiological mechanisms”, Postgrad Med J, Nov;54(637):755-9, PMID: 34143
  11. Behan WMH, Holt J, Kay DH, Moonic P (1999), “In vitro Study of Muscle Aerobic Metabolism in Chronic Fatigue Syndrome”, Journal of Chronic Fatigue Syndrome
  12. Bell DS (2000), “Faces of CFS. Case Histories of Chronic Fatigue Syndrome”, Lyndonville, New York
  13. Blatter BM, Van den Berg R, Van Putten DJ (2005), “Werk, uitval en reïntegratie bij patiënten met ME/CVS”, Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 13:198-204, juli
  14. Blatter BM, Van den Berg R, Van Putten DJ (2005), “Bedrijfs- en verzekeringsartsen over ME/CVS: visie en praktijk”, Tijdschrift Bedrijfs Verzekeringsgeneeskunde, 13:265–270, september
  15. Booth NE, Myhill S. McLaren-Howard J (2012), “Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)”, Int J Clin Exp Med 2012;5(3):208-22, PMID: 2283779
  16. Bouchard C, An P, Rice T, Skinner JS, Wilmore JH, Gagnon J, Russe LP, Leon AS, Rao DC (1999), “Familial aggregation of VO2max response to exercise training: results from the HERITAGE Family Study”, J Appl Physiol 87:1003-1008
  17. Brenu EW, Van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM (2011), “Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis”, Journal of Translational Medicine, 9:81, PMID: 21619669
  18. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, e.a. (1992), “A Chronic Illness Characterised by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection”, Ann Intern Med, Jan 15;116(2):103-13, PMID: 1309285
  19. Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffrench R, Khanna R, Lloyd A (2006), “Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load“, JID 193 (1 March):664-671
  20. Carruthers BM, Jain AK, DeMeirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles ACP, Sherkey JA, Van de Sande MI (2003), “Myalgic Encephalomyelitis / Chronic Fatigue Syndrome : Clinical Working case Definition, Diagnostic and Treatment Protocols”, Journal of Chronic Fatigue Syndrome, Vol. 11 (1)
  21. Carruthers BM, Van de Sande M (2005), “Myalgic Encephalomyelitis / Chronic Fatigue Syndrome: a clinical case definition and guidelines for medical practitioners. An overview of the Canadian Consensus Document”, ISBN 0-9739335-0-X
  22. Carruthers BM, Van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S (2011), “Myalgic encephalomyelitis: International Consensus Criteria”, J Intern Med. 2011 Oct;270(4):327-338, PMID: 21777306, doi: 10.1111/j.1365-2796.2011.02428, Epub 2011 Aug 22
  23. Caseras X, Mataix-Cols D, Giampietro V, Rimes KA, Brammer M, Zelaya F, Chalder T, Godfrey EL (2006), “Probing the Working Memory System in Chronic Fatigue Syndrome: A Functional Magnetic Resonance Imaging Study Using the n-Back Task”, Psychosom Med, Nov-Dec;68(6):947-55. Epub 2006 Nov 1, PMID: 17079703
  24. Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, Taylor DJ (2002), “Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study”, Brain Jul;125(Pt 7):1635-45, PMID: 12077012
  25. Chaudhuri A, Behan OB (2000), “Neurological Dysfunction in Chronic Fatigue Syndrome”, JFCS 6(3/4):51-68
  26. Chen R, Moriya J, Yamakawa JI, Takahashi T, Li Q, Morimoto S, Iwai K, Sumino H, Yamaguchi N, Kanda T (2008), “Brain Atrophy in a Murine Model of Chronic Fatigue Syndrome and Beneficial Effect of Hochu-ekki-to (TJ-41)”, Neurochem Res. Sep;33(9):1759-67. Epub 2008 Mar 4, PMID: 18317925
  27. Chia JKS (2005), “The role of enterovirus in chronic fatigue syndrome”, J Clin Pathol 58:1126-1132, PMID: 16254097, doi:10.1136/jcp.2004.020255
  28. Chia JKS, Chia AY (2008), “Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach”, J Clin Pathol, Jan;61(1):43-8, Epub 2007 Sep 13, PMID: 17872383
  29. Chia JK, Chia AA (2009), “Varicella-zoster virus reactivation during acute enterovirus infection is associated with CD8 lymphocytopenia”, BMJ Case Rep, pii: bcr08.2008.0803, Epub 2009 Mar 5, PMID: 21686623
  30. Chia JKS, Chia AY, Voeller M, Lee T, Chang R (2010): “Acute enterovirus infection followed by myalgic encephalomyelitis /chronic fatigue syndrome (ME/CFS) and viral persistence”, J Clin Pathol Feb;63(2):165-8, Epub 2009 Oct 14, PMID: 19828908, doi: 10.1136/jcp.2009.070466 – full text wanted
  31. Cocchetto A (2003), “Total Exposure: Expanded Model for RNase L Fragmentation in CFS Uncovered; The National CFIDS Foundation Announces the Use of Elastase Inhibitors as a Potential Treatment for CFS Patients”, Investigative Report By Alan Cocchetto, Medical Director, NCF, Inc
  32. Coronel Instituut voor Arbeid en Gezondheid (2012), “Niet-Aangeboren Hersenletsel en Arbeidsparticipatie”, multidisciplinaire richtlijn voor beoordelen, behandelen en begeleiden, Amsterdam
  33. De Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, Van der Meer JWM, Toni I (2005), “Gray matter volume reduction in the chronic fatigue syndrome”, NeuroImage, Jul 1;26(3):777-81, Epub 2005 Apr 7, PMID: 15955487
  34. De Meirleir KL, Khaiboullina SF, Frémont M, Hulstaert J, Rizvanov AA, Palotás A, Lombardi VC (2013), “Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins“, In Vivo, Mar;27(2):177-87, PMID: 23422476
  35. De Veer AJE, Francke AL (2008), “Zorg voor ME/CVS-patiënten. Ervaringen van de achterban van patiëntenorganisaties met de Gezondheidszorg”, NIVEL, december
  36. Den Broeder G (2007), “Richtlijnen en Knelpunten voor ME/CVS”, ME/CVS Vereniging, Lees ME 2, mei, p10-15
  37. Den Broeder G (2008), “Testen op ME/CVS”, ME/CVS Vereniging, Lees ME 5, juli, p37-41 en Lees ME 6, december, p28-31
  38. Den Broeder G (2011), “Knelpunten in de zorg voor ME-patiënten”, presentatie Landelijke ME informatiedag, Driebergen, 12 mei
  39. Den Broeder G (2014), “De postvirale hersenaandoening Myalgische Encefalomyelitis. Stand van zaken 2014”, ME Vereniging Nederland, 29 maart
  40. Dowsett EG, Ramsay AM, McCartney RA, Bell EJ (1990), “Myalgic Encephalomyelitis (M.E.) — A Persistent Enteroviral Infection?”, Postgraduate Medical Journal, 66:526-530
  41. Drexhage R (2011), “Immuno-neuro-endocrine networks. A study on the inflammatory state of circulating monocytes and CD4+ T cells in psychiatric and endocrine autoimmune disease” (proefschrift), Erasmus MC, Rotterdam, ISBN: 978-90-5335-405-6
  42. Englebienne P, De Meirleir K (red.) (2002), “Chronic Fatigue Syndrome. A Biological Approach”, CRC Press, Boca Raton, ISBN 0-8493-1046-6
  43. ErkenME (2009), “Petitie aan de Commissie VWS van de Tweede Kamer der Staten-Generaal inzake Myalgische Encefalomyelitis”, 12 mei
  44. Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R (2002), “Blood volume and its relation to peak O2 consumption and physical activity in patients with chronic fatigue”, Am J Physiol Heart Circ Physiol, Jan;282(1):H66-71, PMID: 11748048
  45. Fessel J, Robertson D (2006), “Orthostatic hypertension: when pressor reflexes overcompensate”, Nat Clin Pract Nephrol Aug;2(8):424-31, PMID: 16932477
  46. Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O (2011), “Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study“, PLoS ONE 6(10): e26358, doi:10.1371/journal.pone.0026358
  47. Food and Drug Administration (2013), “The Voice of the Patient. Chronic Fatigue Syndrome and Myalgic Encephalomyelitis”, Silver Spring, september
  48. Freeman ML, Burkum CE, Jensen MK, Woodland DL, Blackman MA(2012), “γ-Herpesvirus Reactivation Differentially Stimulates Epitope-Specific CD8 T Cell Responses”, Immunology, 2012 doi: 10.4049/jimmunol.1102787, PMID: 22407914
  49. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A (1994), “The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group”, Annals of Internal Medicine Dec 15;121(12):953-9, PMID: 7978722
  50. Gezondheidsraad (2003), “Voedingsnormen vitamine B6, foliumzuur en vitamine B12”, Den Haag, nr 2003/04, 12 februari, ISBN: 90-5549-470-4
  51. Gibson I, e.a. (2006), “Inquiry into the status of CFS / M.E. and research into causes and treatment”, Group in Scientific Research into Myalgic Encephalomyelitis (M.E.), Londen, Engeland
  52. Gilliam AG (1938), “Epidemiological Study on an Epidemic, Diagnosed as Poliomyelitis, Occurring among the Personnel of Los Angeles County General Hospital during the Summer of 1934”, United States Treasury Department Public Health Service Public Health Bulletin, No. 240, pp. 1-90. Washington, DC, Government Printing Office
  53. Goldstein J (1996), “Betrayal by the Brain: Neurological Basis of Chronic Fatigue Syndrome, Fibromyalgia Syndrome and Related Neural Network Disorders”, Haworth Medical Press, Binghamton, New York, ISBN 1560249811
  54. Graham J (2001), “Chronic Fatigue Syndromes – a review”, Journal of Australian College of Nutritional & Environmental Medicine Aug 20(2):19-28
  55. Heckenlively K, Judy Mikovits J. (2014), “Plague: One Scientist’s Intrepid Search for the Truth about Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism, and Other Diseases”, November 18, ISBN-13: 978-1626365650
  56. Hempel S, Chambers D, Bagnall AM, Forbes C (2007), “Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies”, Psychol Med, Jul;38(7):915-26, Epub 2007 Sep 25, PMID: 17892624
  57. Henke A, Huber S, Stelzner A, Whitton JA (1995), “The Role of CD8+ T Lymphocytes in Coxsackievirus B3-Induced Myocarditis”, Journal of Virology 69:11, nov, p6720–6728
  58. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A (2006), “Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study”, BMJ, Sep 16;333(7568):575, Epub 2006 Sep 1, PMID: 16950834
  59. Hokama Y, Campora CE, Hara C, Kuribayashi T, Le Huynh D, Yabusaki K (2009), “Anticardiolipin Antibodies in the Sera of Patients with Diagnosed Chronic Fatigue Syndrome”, Clin Lab Anal, 23(4):210-2, PMID: 19623655
  60. Holmes G, Kaplan J, Gantz N, Komaroff A, Schonberger L, Straus S, Jones J, Dubois R, Cunningham-Rundles C, Pahwa S, e.a. (1988), “Chronic fatigue syndrome: a working case definition”, Ann Intern Med, Mar;108(3):387-9, PMID: 2829679
  61. Hoogeveen AR (2000), “De diagnostische mogelijkheden van spiroergometrisch onderzoek bij patiënten met een verdenking op een mitochondriële myopathie“, Ned Tijdschr Klin Chem 25:27-30
  62. Hooper M (2007), “Myalgic encephalomyelitis: a review with emphasis on key findings in biomedical research”, J Clin Pathol, May;60(5):466-71, Epub 2006 Aug 25, PMID: 16935967
  63. Hooper M (2010), “Magical Medicine: how to make a disease disappear”, University of Sunderland, februari
  64. Hornig, Montoya, Klimas, Levine, Felsenstein, Bateman, Peterson, Gottschalk, Schultz, Che, Eddy, Komaroff, Lipkin (2015), “Distinct plasma immune signatures in ME/CFS are present early in the course of illness”, Science Advances, 27 februari
  65. Hyde BM (red.) (1992), “The Clinical and Scientific Basis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome”, Nightingale Research Foundation, Ottawa, Canada with editorial and conceptual advice from Levine P and Goldstein J, ISBN 0-9695662-0-4
  66. Hyde BM (2003), “The Complexities of Diagnosis” [5], in: Jason LA, Fennel PA, Taylor RR, “Handbook of Chronic Fatigue Syndrome”, John Wiley & Sons, ISBN 0-471-41512-X
  67. Hyde BM (2007), “The Nightingale Myalgic Encephalomyelitis (M.E.) Definition”, The Nightingale Research Foundation, Ottawa, Canada
  68. Hyde BM (2011), “The Nightingale Research Foundation Definition of Myalgic Encephalomyelitis (M.E.)”, The Nightingale Research Foundation, Ottawa, Canada, september
  69. International Labour Organization (2011), “Social protection floor for a fair and inclusive globalization”, Report of the Advisory Group chaired by Michelle Bachelet, Convened by the ILO with the collaboration of the WHO
  70. Jason LA (2011), “Small Wins Matter in Advocacy Movements: Giving Voice to Patients”, Am J Community Psychol, Aug 20 [Epub ahead of print], PMID: 21858612
  71. Jason L, Benton M, Torres-Harding S, Muldowney K (2009), “The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS”, Patient Educ Couns, Nov;77(2):237-41, Epub 2009 Apr 8, PMID: 19356884
  72. Jason LA, Corradi K, Gress S, Williams S, Torres-Harding S (2006), “Causes of death among patients with chronic fatigue syndrome“, Health Care Women Int Aug;27(7):615-26, PMID: 16844674
  73. Jason LA, Damrongvachirapan D, Hunnell J, Bartgis L, Brown A, Evans M, Brown M (2011), “Myalgic Encephalomyelitis Case Definitions”, Ashdin Publishing: Automatic Control of Physiological State and Functioning, Vol. 1 (2012), doi:10.1403/acpsf/K110601
  74. Jason LA, Fennel PA, Taylor RR (2003), “Handbook of Chronic Fatigue Syndrome”, John Wiley & Sons, ISBN 0-471-41512-X
  75. Jason LA, Jordan K, Miike T, Bell DS, Lapp C, Torres-Harding S, Rowe K, Gurwitt A, DeMeirleir K, Van Hoof ELS (2006), “A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome”, The Haworth Press
  76. Jason LA, Sorenson M, Porter N, Belkairous N (2010), “An Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”, Neuroscience & Medicine, 2011, 2, 14-27, PMID: 21892413, doi:10.4236/nm.2011.21003 Published Online March 2011
  77. Jason LA, Taylor RR, Plioplys S, Stepanek Z, Shlaes J (2002), “Evaluating attributions for an illness based upon the name: chronic fatigue syndrome, myalgic encephalopathy and Florence Nightingale disease”, Am J Community Psychol 30(1):133–48, PMID=11928774
  78. Jason LA, Torres-Harding SR, Jurgens A, Helgerson J (2004), “Comparing the Fukuda et al. Criteria and the Canadian Case Definition for Chronic Fatigue Syndrome”, Journal of Chronic Fatigue Syndrome, vol.12 p:39-52
  79. Jones DE, Hollingsworth KG, Taylor R, Blamire AM, Newton J (2010), “Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome“, J Intern Med Apr;267(4):394-401, PMID: 20433583
  80. Kaushik N, Fear D, Richards SCM, McDermott CR, Nuwaysir EF, Kellam P, Harrison TJ, Wilkinson RJ, Tyrrell DAJ, Holgate ST, Kerr JR (2005), “Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome”, J Clin Pathol, Aug;58(8):826-32, PMID: 16049284
  81. Keighley BD, Bell EJ (1983), “Sporadic myalgic encephalomyelitis in a rural practice”, J R Coll Gen Pract, Jun;33(251):339-41, PMID: 6310105
  82. Kindlon T (2011), “Reporting of Harms Associated with Graded Exercise Therapy and Cognitive Behavioural Therapy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”, Bulletin of the IACFS/ME, 19(2):59-111
  83. Kuratsune H, Yamaguti K, Lindh G, Evengard B, Takahashi M, Machii T, Matsumura K, Takaishi J, Kawata S, Langstrom B, Kanakura Y, Kitani T, Watanabe Y (1998), “Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases”, Int J Mol Med. Jul;2(1):51-6, PMID: 9854142
  84. Kuratsune H, Yamaguti K, Takahashi M, e.a. (1994), “Acylcarnitine deficiency in chronic fatigue syndrome”, Clin Infect Dis, Jan;18 Suppl 1:S62-7, PMID: 8148455
  85. Lane RJ, Barrett MC, Taylor DJ, Kemp GJ, Lodi R (1998), “Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle”, Neuromuscul Disord, May;8(3-4):204-9, PMID: 9631403
  86. Lane RJM, Soteriou BA, Zhang H, Archard LC (2003), “Enterovirus related metabolic myopathy: a postviral fatigue syndrome”, Journal of Neurology, Neurosurgery and Psychiatry Oct;74(10):1382-6, PMID: 14570830
  87. Lenzer J, Hoffman JR, Furberg CD, Ioannidis JPA (2013), “Clinical guidelines. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients”, On behalf of the Guideline Panel Review working group, BMJ 347, doi:10.1136/bmj/f5535, 17 September
  88. Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT, Lemeshow S, Glaser R (2012), “Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset“, PLoS One, 7(11): e47891, PMID: 23155374
  89. Lerner M, Beqaj S, Fitzgerald JT, Gill K, Gill C, Edington J (2010), “Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome“, Virus Adaptation and Treatment, mei, Volume 2010:2, p.47-57, doi:10.2147/VAAT/S10695
  90. Lerner AM, Zervos M, Dworkin HJ, Chang CH, O’Neill W (1997), “A unified theory of the cause of chronic fatigue syndrome”, Infectious Diseases in Clinical Practice, 6:239-243
  91. Levine PH (1996), “The use of transfer factors in chronic fatigue syndrome: prospects and problems”, Biotherapy, 9(1-3):77-9, PMID: 8993762 – full text wanted
  92. Levine S (2001), “Prevalence in the cerebro spinal fluid of the following infectious agents in a cohort of 12 CFS subjects: Human Herpes Virus 6 & 8; Chlamydia Species; Mycoplasma Species, EBV; CMV and Coxsackie B Virus”, Journal of Chronic Fatigue Syndrome, 9:91-2:41-51
  93. Light AR, Bateman L, Jo D, Hughen RW, Vanhaitsma TA, White AT, Light KC (2012), “Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome”, J Intern Med Jan;271(1):64-81, PMID: 21615807, doi: 10.1111/j.1365-2796.2011.02405.x, Epub 2011 Jul 13
  94. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulácsy V, Chernyshova L, Chernyshov V, Bondarenko A, Grimaldo RM, Blancas-Galicia L, Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bué M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Maródi L, Boisson-Dupuis S, Puel A, Casanova JL (2011), “Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis”, J Exp Med, Aug 1;208(8):1635-48, Epub 2011 Jul 4
  95. Lo S-C, Pripuzova N, Li B, Komaroff AL, Hung G-C, Wang R, Alter HJ (2010), “Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors”, Proceedings of the National Academy of Sciences, USA, Sep 7;107(36):15874-9, Epub 2010 Aug 23, PMID: 20798047
  96. Loebel M, Strohschein K, Giannini C, Koelsch U, Bauer S, Doebis C, Thomas S, Unterwalder N, Von Baehr V, Reinke P, Knops M, Hanitsch LG, Meisel C, Volk H-D, Scheibenbogen C (2014), “Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome”, PLoS ONE 9(1): e85387, doi:10.1371/journal.pone.0085387
  97. Lombardi VC, Hegen KS, Hunter KW, Diamond JW, Smith-Gage J, Yang W, Mikovits JA (2011), “Xenotropic Murine Leukemia Virus-related Virus-associated Chronic Fatigue Syndrome Reveals a Distinct Inflammatory Signature”, In Vivo May-Jun;25(3):307-14, PMID: 21576403
  98. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA (2009), “Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome”, Science, Oct;8, PMID: 19815723
  99. Lundell K, Qazi S, Eddy L, Uckun FM (2006), “Clinical activity of folinic acid in patients with chronic fatigue syndrome”, Arzneimittelforschung, 56(6):399-404, PMID: 16889122 – full text wanted
  100. Mackie Ph (2009), “Health Care Needs Assessment of Services for people living with ME-CFS – draft for consultation”, 6 mei, ScotPHN report
  101. Magnusson M, Brisslert M, Zendjanchi K, Lindh M, Bokarewa MI (2010), “Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment”, Rheumatology (Oxford), Oct;49(10):1911-9, Epub 2010 Jun 14
  102. Maher KJ, Klimas NG, Fletcher MA (2005), “Chronic fatigue syndrome is associated with diminished intracellular perforin”, Clin Exp Immunol, Dec;142(3):505-11, PMID: 16297163
  103. Marshall EP, Williams M, Hooper M (2001), “What is ME? What is CFS? Information for clinicians and lawyers”, Engeland
  104. Macintyre A (1997), “Eye Problems in CFS/ME”, Perspectives, september
  105. Meeus M, Mistiaen W, Lambrecht L, Nijs J (2009), “Immunological similarities between cancer and chronic fatigue syndrome: the common link to fatigue?”, Anticancer Res, Nov;29(11):4717-26, PMID: 20032425
  106. Morris G, Maes M (2012), “A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome”, Metab Brain Dis, Jun 21, epub ahead of print, PMID: 22718491 – full text wanted
  107. Morris G, Maes M (2013), “Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata / multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics”, BMC Medicine 2013, 11:205
  108. Morris G, Maes M (2013), “Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions”, Neuro Endocrinol Lett 34(3):185-99, PMID: 23685416
  109. Myhill S, E Booth ME, McLaren-Howard J (2013), “Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) – a clinical audit”, Int J Clin Exp Med, 6(1): 1–15, PMID: 23236553
  110. Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, Leite JCDC, Poland F, Howe A, Drachler ML (2011), “Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care”, BMC Medicine 2011, 9:91, PMID: 21794183
  111. Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y (2014), “Neuroinflammation in Patients with Chronic Fatigue Syndrome /Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study”, J Nucl Med, Mar 24, epub ahead of print, PMID: 24665088
  112. Nasjonalt kunnskapssenter for helsetjenesten (2006), “Diagnostisering og behandling av kronisk utmattelsessyndrom / myalgisk encefalopati (CFS/ME)”, Nr 9-2006, ISBN 82-8121-097-4
  113. National Institutes of Health (2011), “Myalgic Encephalomyelitis/Chronic FatigueSyndrome (ME/CFS) Research”, State of the Knowledge Workshop report, 7/8 April, Bethesda, Maryland
  114. National Institute for Health and Clinical Excellence (2007), “Chronic fatigue syndrome / Myalgic encephalomyelitis (or encephalopathy); diagnosis and management”, Londen
  115. Niblett SH, King KE, Dunstan RH, Clifton-Bligh P, Hoskin LA, Roberts TK, Fulcher GR, McGregor NR, Dunsmore JC, Butt HL, Klineberg I, Rothkirch TB (2007), “Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome”, Exp Biol Med (Maywood), Sep;232(8):1041-9, PMID: 17720950
  116. Nijs J, Meeus M, Mcgregor NR, Meeusen R, De Schutter G, Van Hoof E, De Meirleir K (2005), “Chronic Fatigue Syndrome: Exercise Performance Related to Immune Dysfunction”, Med Sci Sports Exerc, Oct;37(10):1647-54, PMID: 16260962
  117. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N (2004), “Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome”, BMC Neurology, Oct 4;4(1):14, PMID: 15461817
  118. Pall ML (2002), “Levels of nitric oxide synthase product citrulline are elevated in sera of chronic fatigue syndrome patients”, Journal of Chronic Fatigue Syndrome 10(3/4):37-41
  119. Parish JG (1978), “Early outbreaks of ‘epidemic neuromyasthenia'”, Postgraduate Medical Journal, Nov;54(637):711-7, PMID: 370810
  120. Peckerman A, Lamanca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH (2003), “Abnormal impedence cardiographic predicts symptom severity in Chronic Fatigue Syndrome”, Am J Med Sci, Aug;326(2):55-60, PMID: 12920435,
  121. Pellew RA, Miles JA (1955), “Further investigations on a disease resembling poliomyelitis seen in Adelaide”, Medical Journal of Australia, Sep 24;2(13):480-2, PMID: 13272481
  122. Pender MP (2011), “The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis”, Neuroscientist, Aug;17(4):351-67, PMID: 21075971
  123. Pender MP (2012), “CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis”, Autoimmune Dis, PMID: 22312480
  124. Pheby D, Saffron L (2009), “Risk factors for severe ME/CFS”, J Biol Med, 1(4):50-74
  125. Poser CM (1992), “The Differential Diagnosis between Multiple Sclerosis and Chronic Fatigue Postviral Syndrome”, in: Byron M. Hyde (red.), “The Clinical and Scientific Basis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome”, Nightingale Research Foundation, Ottawa, ISBN 0-9695662-0-4
  126. Puri BK, Counsell SJ, Zaman R, Main J, Collins AG, Hajnal JV, Davey NJ (2002), “Relative increase in choline in the occipital cortex in chronic fatigue syndrome”, Acta Psychiatr Scand, Sep;106(3):224-6, PMID: 12197861
  127. Quenelle DC, Lampert B, Collins DJ, Rice TL, Painter GR, Kern ER (2010), “Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies“, J Infect Dis, 2010 Nov 15;202(10):1492-9, Epub 2010 Oct 5, PMID: 20923374
  128. Ramsay AM (1986), “Postviral Fatigue Syndrome. The saga of Royal Free disease”, Londen, ISBN 0-906923-96-4
  129. Ramsay AM, Dowsett EG (1992), “Myalgic Encephalomyelitis — Then and Now: An Epidemiological Introduction”, in: Byron M. Hyde (red.), “The Clinical and Scientific Basis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome”, Nightingale Research Foundation, Ottawa, ISBN 0-9695662-0-4, hoofdstuk 4, blz. 81-84
  130. Regieraad Kwaliteit van Zorg (2011), “Richtlijn voor Richtlijnen”, april (herziene versie)
  131. Robertson ES (red.) (2010), “Epstein-Barr Virus: Latency and Transformation”, Caister Academic Press, april, ISBN 978-1-904455-64-6
  132. Roelant C, De Meirleir K (2012), “Self-test monitoring of the Th1/Th2 balance in health and disease with special emphasis on chronic fatigue syndrome /myalgic encephalomyelitis”, Journal of Medical Laboratory and Diagnosis, 3(1):1-6, doi: 10.5897/JMLD11.023
  133. Rosati G (2001), “The prevalence of multiple sclerosis in the world: an update”, Neurol Sci Apr;22(2):117-39, PMID: 11603614
  134. Sadun AA, Dugel PU (1992), “Neuro-opthalmological Manifestations of Chronic Fatigue Syndrome”in: Byron M. Hyde (red.), “The Clinical and Scientific Basis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome”, Nightingale Research Foundation, Ottawa, ISBN 0-9695662-0-4
  135. Schwartz RB, Garada BM (1994), “Detection of Intracranial Abnormalities in Patients with Chronic Fatigue Syndrome. Comparison of MR Imaging and SPECT”, AJR Am J Roentgenol, Apr;162(4):935-41, PMID: 8141020
  136. Shapiro JS (2009), “Does varicella-zoster virus infection of the peripheral ganglia cause Chronic Fatigue Syndrome?”, Medical Hypotheses Volume 73, Issue 5, November 2009, Pages 728-734, PMID: 19520522, doi:10.1016/j.mehy.2009.04.043
  137. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, Mathew SJ (2012), “Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology”, NMR Biomed. 2012 Jan 27. doi: 10.1002/nbm.2772, epub ahead of print, PMID: 22281935 – full text wanted
  138. Silver JS, Hunter CA (2010), “gp130 at the nexus of inflammation, autoimmunity, and cancer”, J Leukoc Biol December; 88(6): 1145–1156, PMID: 20610800
  139. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett Jr. J, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo S-C, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP (2011), “Failure to Confirm XMRV/MLVs in the Blood of Patients with Chronic Fatigue Syndrome: A Multi-Laboratory Study”, Science, Sep 22, Epub ahead of print, PMID: 21940862
  140. Snow AL, Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM (2006), “EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis”, J Immunol, Sep 1;177(5):3283-93, PMID: 16920969
  141. Snyder KA (2000), “I Remember Me” (DVD), Loka Motion Productions, Inc.
  142. South Australian Department of Human Services (2004), “ME/CFS Guidelines. Myalgic Encephalopathy (ME) / Chronic Fatigue Syndrome (CFS). Management Guidelines for General Practitioners”, ISBN 0-7308-9334-0
  143. Stehouwer CDA (2002), “Veronderstellingen over oorzaken van ziekte zijn wel weerlegbaar, maar niet bewijsbaar”, Bijblijven, 18, p. 39-46
  144. Stein E (2001), “How to differentiate CFS from Psychiatric Disorder”, Presented at The Alison Hunter Memorial Foundation Third International Clinical and Scientific Conference, Sydney, Australia
  145. Stein E (2005), “Assessment and Treatment of Patients with ME/CFS: Clinical Guidelines for Psychiatrists“
  146. Stein E (2013), “Identifying and Treating Common Psychiatric Conditions Comorbid with Myalgic Encephalomyelitis and/or Fibromyalgia”, Psychiatric Times,30(1)
  147. Stewart CC, Cookfair DL, Hovey KM, Wende KE, Bell DS, Warner CL (2003), “Predictive immunophenotypes: disease-related profile in chronic fatigue syndrome”, Cytometry B Clin Cytom. May;53(1):26-33, PMID: 12717688
  148. Stichting ME Research (2014), “Doorlopende Enquête Patiёntenperspectief onder de leden van de ME Vereniging Nederland. Overzicht 2012-2013”, 8 februari
  149. Suhadolnik RJ, Peterson DL, O’Brien K, Cheney PR, Herst CVT, Reichenbach NL, Kon N, Horvath SE, Iacono KT, Adelson ME, De Meirleir K, De Becker P, Charubala R, Pfleiderer W (1997), “Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome”, J Interferon Cytokine Res, Jul;17(7):377-85, PMID: 9243369
  150. Suhadolnik RJ, Peterson DL, Reichenbach NL, Roen G, Metzger M, McCahan J, O’Brien K, Welsch S, Gabriel J, Gaughan JP, McGregor NR (2004), “Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction and RNase L Pathway”, Journal of Chronic Fatigue Syndrome, Vol. 12, Number 1, pp. 5-35, ISSN: 1057-3321
  151. Tanaka M, Sadato N, Okada T, Mizuno K, Sasabe T, Tanabe HC, Saito DN, Onoe H, Kuratsune H, Watanabe Y (2006), “Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study”, BMC Neurol, Feb 22;6:9, PMID: 16504053
  152. The AGREE Collaboration (2001), “Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument”, St George’s Hospital Medical school, Londen, juni
  153. The AGREE Next Step Consortium (2013), “Appraisal of Guidelines for Research & Evaluation II“, september, Ontario, Canada (update van mei 2009)
  154. The Medical Staff of the Royal Free Hospital (1957), “An outbreak of encephalomyelitis in the Royal Free Hospital Group, London, in 1955”, Br Med J, Oct 19;2(5050):895-904, PMID: 13472002
  155. Tijdelijk Instituut voor Coördinatie en Afstemming (1996), “Richtlijn Medisch Arbeidsongeschiktheids Criterium”, mededeling 19 september, nr. M 96 122
  156. Tzartos JS, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, Sefia E, Meager A, Elia A, Middeldorp JM, Clemens M, Farrell PJ, Giovannoni G, Meier UC (2012), “Association of innate immune activation with latent Epstein-Barr virus in active MS lesions”, Neurology, Jan 3;78(1):15-23, epub 2011 Dec 7, PMID: 22156987 – full text wanted
  157. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL (2006), “Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant”, PLoS Pathog, Mar;2(3):e25, PMID: 16609730
  158. VanNess JM, Snell CR, Stevens SR, Bateman L, Keller BA (2006), “Using Serial Cardiopulmonary Exercise Tests to Support a Diagnosis of Chronic Fatigue Syndrome”, Med Sci Sports Exerc 38(5)
  159. Vernon S, Whistler T, Cameron B, Hickie I, Reeves W, Lloyd A (2006), “Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus”, BMC Infect Dis. Jan 31;6 (1):15, PMID: 16448567
  160. Versluis RG, de Waal MW, Opmeer C, Petri H, Springer MP (1997), “Prevalence of chronic fatigue syndrome in 4 family practices in Leiden”, Ned Tijdschr Geneeskd, Aug 2;141(31):1523-6, PMID: 9543740
  161. Wallis AL (1957), “An investigation into an unusual illness seen in Epidemic and Sporadic Form in a General Practice in Cumberland in 1955 and subsequent years”, M.D. Thesis, Edinburgh University
  162. White PD (2007), “What Causes Prolonged Fatigue after Infectious Mononucleosis and Does It Tell Us Anything about Chronic Fatigue Syndrome?”, J Infect Dis, Jul 1;196(1):4-5, Epub 2007 May 24, PMID: 17538875
  163. World Health Organization (1992), “International Statistical Classification of Diseases and Related Health Problems”, WHO, ISBN 92-4-154419-8 (vol. 1), ISBN 92-4154420-1 (vol. 2) en ISBN 92-4-154421-X (vol. 3)
  164. World Health Organization (2001), “International Classification of Functioning, Disability and Health”, WHO, Geneva, ISBN 92-4-154542-9
  165. Wyller VB, Due R, Saul JP, Amlie JP, Thaulow E (2007), “Usefulness of an abnormal cardiovascular response during low-grade head-up tilt-test for discriminating adolescents with chronic fatigue from healthy controls”, Am J Cardiol, Apr 1;99(7):997-1001, epub 2007 Feb 16, PMID: 17398200
  166. Xu S, Gaskin F (1997), “Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer’s disease”, Mech Ageing Dev, Mar;94(1-3):213-22, PMID: 9147373
  167. Yamamoto Y, LaManca JJ, Natelson BH (2003), “A measure of heart rate variability is sensitive to orthostatic challenge in women with chronic fatigue syndrome”, Exp Biol Med (Maywood), Feb;228(2):167-74, PMID: 12563023

Zie ook

Contact

Wij zijn benieuwd naar uw verhaal.

Not readable? Change text. captcha txt

Start typing and press Enter to search